UnitedHealth CEO Defends Company As Stock Sinks on Earnings
Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.
UnitedHealth’s Revenues Rise, in First Earnings Report Since C.E.O.’s Killing
But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.
UnitedHealth to report first earnings since exec’s murder
UnitedHealth Group’s upcoming earnings call marks the company's first public appearance since the murder of UnitedHealthcare CEO Brian Thompson.
UnitedHealth Q4 Earnings: Revenue Falls Short, Medical Ratio Rises To 85.5%, Stock Falls
UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.
UnitedHealth CEO calls out pharmaceutical companies for inflating prices in first earnings call since executive was murdered
Revenue grew to over $400 billion, but still missed growth targets.
United Health boss defends firm in first earnings results since CEO killing
The CEO of UnitedHealth Group has defended its role in America's health system as the company posted its first earnings results since the murder of one of its top executives. Sir Andrew Witty spoke to analysts as the firm reported mixed results,
UnitedHealth Group CEO acknowledges frustrations with US health care system
The UnitedHealth Group leader whose murder in December unleashed a torrent of public frustration and dissatisfaction with the U.S. health care system was pushing for some of the very improvements that critics have been seeking.
UnitedHealth stock reiterate Outperform rating on earnings results
Bernstein analysts maintained their positive stance on UnitedHealth Group (NYSE:UNH) shares, reiterating an Outperform rating and a price target of $697.00. The reaffirmation follows UnitedHealth's latest quarterly financial report,
UnitedHealth shares fall 5% after first earnings report since insurance CEO’s murder
UnitedHealth shares dropped nearly 5% Thursday morning after the firm disclosed worse-than-expected revenue in its first earnings report since the shocking assassination of Brian Thompson, its insurance branch’s chief executive.
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
Benefits Pro2d
UnitedHealth's PBM will pass 100% of rebates on to clients: Will more big PBMs follow?
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Hosted on MSN1d
UnitedHealth marked up lifesaving drugs by up to 1,000%: FTC
According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS ...
How UnitedHealth and Rivals Made $7.3 Billion Marking Up Drugs: FTC
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
Latin Times on MSN2d
UnitedHealth Is Price Gouging Cancer Patients by Overcharging 'Thousands of Percent' for Live-Saving Meds, Pocketing Extra Billions: Feds
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...